DefenAge Revenue and Competitors

Location

N/A

Total Funding

Cosmetics

Industry

Estimated Revenue & Valuation

  • DefenAge's estimated annual revenue is currently $2.9M per year.(i)
  • DefenAge's estimated revenue per employee is $140,000

Employee Data

  • DefenAge has 21 Employees.(i)
  • DefenAge grew their employee count by -22% last year.

DefenAge's People

NameTitleEmail/Phone
1
VP Digital StrategyReveal Email/Phone
2
Associate VP Brand Strategy and GrowthReveal Email/Phone
3
Director Customer ExperienceReveal Email/Phone
4
Marketing DirectorReveal Email/Phone
5
Director EcommerceReveal Email/Phone
6
Director MarketingReveal Email/Phone
7
Fulfillment ManagerReveal Email/Phone
8
Account Executive Central ValleyReveal Email/Phone
9
Account ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M3934%N/AN/A
#2
$35M15610%N/AN/A
#3
$3.5M11-39%N/AN/A
#4
$15M6467%N/AN/A
#5
$7.5M18721%N/AN/A
#6
$11.2M8060%N/AN/A
#7
$3.5M370%N/AN/A
#8
$7.5M5121%N/AN/A
#9
$15M60511%N/AN/A
#10
$4.2M303%N/AN/A
Add Company

What Is DefenAge?

Comprehensive Multicenter Clinical Study shows that DefenAge’s core skin care regimen addressed visible signs of skin aging on a global scale (randomized, placebo/vehicle-controlled, double-blinded study; 44 participants). The wide-range visible improvement of aging skin was confirmed by multiple advanced methods of evaluation of skin conditions including histopathology and high-resolution skin ultrasound. The study has been performed by Dr. Amy Forman Taub (PI), Dr. Vivian Bucay and Dr. Gregory Keller. DefenAge’s exclusive ingredient, Age-Repair Defensins®, works via a natural mechanism of action. The technology is patent-pending, can be combined with almost any skin care regimen and is exclusively available at DefenAge.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$2.9M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M21-5%N/A
#2
$2.9M2140%N/A
#3
$2.1M21N/AN/A
#4
$2.1M21N/AN/A
#5
$2.1M210%N/A